['Zinc-α(2) glycoprotein (ZAG) stimulates lipid loss by adipocytes and may be involved in the regulation of adipose tissue metabolism. However, to date no studies have been made in the most extreme of obesity. The aims of this study are to analyze ZAG expression levels in adipose tissue from morbidly obese patients, and their relationship with lipogenic and lipolytic genes and with insulin resistance (IR).', 'mRNA expression levels of PPARγ, IRS-1, IRS-2, lipogenic and lipolytic genes and ZAG were quantified in visceral (VAT) and subcutaneous adipose tissue (SAT) of 25 nondiabetic morbidly obese patients, 11 with low IR and 14 with high IR. Plasma ZAG was also analyzed.', 'The morbidly obese patients with low IR had a higher VAT ZAG expression as compared with the patients with high IR (p\u200a=\u200a0.023). In the patients with low IR, the VAT ZAG expression was greater than that in SAT (p\u200a=\u200a0.009). ZAG expression correlated between SAT and VAT (r\u200a=\u200a0.709, p<0.001). VAT ZAG expression was mainly predicted by insulin, HOMA-IR, plasma adiponectin and expression of adiponectin and ACSS2. SAT ZAG expression was only predicted by expression of ATGL.'] Is zinc-alpha 2-glycoprotein gene expression in adipose tissue related with insulin resistance and lipolytic genes in morbidly obese patients?